Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 3
2006 1
2008 1
2012 1
2013 2
2014 1
2020 1
2021 2
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean adam svobodnykh (1 results)?
Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.
Munch MW, Granholm A, Maláska J, Stašek J, Rodriguez PO, Pitre T, Wilson R, Savović J, Rochwerg B, Svobodnik A, Kratochvíl M, Taboada M, Jha V, Vijayaraghavan BKT, Myatra SN, Venkatesh B, Perner A, Møller MH. Munch MW, et al. Among authors: svobodnik a. Acta Anaesthesiol Scand. 2024 Feb;68(2):146-166. doi: 10.1111/aas.14346. Epub 2023 Oct 26. Acta Anaesthesiol Scand. 2024. PMID: 37881881 Review.
Palliative care practice and moral distress during COVID-19 pandemic (PEOpLE-C19 study): a national, cross-sectional study in intensive care units in the Czech Republic.
Prokopová T, Hudec J, Vrbica K, Stašek J, Pokorná A, Štourač P, Rusinová K, Kerpnerová P, Štěpánová R, Svobodník A, Maláska J; RIPE-ICU study group. Prokopová T, et al. Among authors: svobodnik a. Crit Care. 2022 Jul 19;26(1):221. doi: 10.1186/s13054-022-04066-1. Crit Care. 2022. PMID: 35854318 Free PMC article.
Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.
Maláska J, Stašek J, Duška F, Balík M, Máca J, Hruda J, Vymazal T, Klementová O, Zatloukal J, Gabrhelík T, Novotný P, Demlová R, Kubátová J, Vinklerová J, Svobodník A, Kratochvíl M, Klučka J, Gál R, Singer M; REMED Study Group. Maláska J, et al. Among authors: svobodnik a. Trials. 2022 Jan 15;23(1):35. doi: 10.1186/s13063-021-05963-6. Trials. 2022. PMID: 35033182 Free PMC article.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Žáčková D, Semerád L, Faber E, Klamová H, Stejskal L, Bělohlávková P, Karas M, Cmunt E, Černá O, Procházková J, Čičátková P, Kvetková A, Horňák T, Skoumalová I, Srbová D, Šálek C, Buffa D, Voglová J, Jurček T, Folta A, Ježíšková I, Žižková H, Machová Poláková K, Papajík T, Žák P, Jindra P, Svobodník A, Štěpánová R, Mayer J. Žáčková D, et al. Among authors: svobodnik a. Leukemia. 2024 Apr;38(4):893-897. doi: 10.1038/s41375-024-02215-9. Epub 2024 Mar 12. Leukemia. 2024. PMID: 38472478 Free PMC article. No abstract available.
20 results